... boosted by strong sales of the anti-seizure medicine Topamax, its Risperdal antipsychotic drug franchise and the anti-infective treatment Levaquin. ...
Global sales of prescription drugs jumped 10.6 percent to $6.2 billion, with strong growth for epilepsy drug Topamax, antibiotic Levaquin and schizophrenia ...
Global Levaquin sales rose 18 percent to $475 million, including a 50- percent increase outside of the United States to $15 million. ...
In the case of Levaquin, Mylan Labs lost at the district court level in a case that it should have won, even under the law as it existed at the time, ...